A Novel Controlled Release Immunosensor based on Benzimidazole Functionalized SiO 2 and Cyclodextrin Functionalized Gold

17Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A novel controlled release system-based sandwich-type immunosensor is fabricated to detect squamous cell carcinoma antigen (SCCA). The 1-methyl-1H-benzimidazole functionalized mesoporous SiO 2 (MBI-MS) is used to load methylene blue (MB). β-cyclodextrin functionalized gold (CD-Au) is introduced as the gatekeeper for encapsulating MB and capturing the adamantly functional detection antibody (ADA-Ab 2). And pH stimulus serves as the trigger system to control the MB release. After the load of MB, the CD-Au blocks the pores of the MBI-MS by the host-guest interaction in the neutral condition. However, when the pH is below 7.0, CD-Au is separated from the surface of MBI-MS owing to the protonation of the aromatic amines. The encapsulated MB is released from the pores of MBI-MS and detected by square wave voltammetry. The controlled release immunosensor shows a relatively wide linear range from 0.001 to 20 ng·mL ' '1 with a low detection limit of 0.25 pg·mL ' '1. The immunosensor also shows good reproducibility and selectivity, which endows it broad application prospect in clinical research.

Cite

CITATION STYLE

APA

Ma, H., Wang, Y., Wu, D., Zhang, Y., Gao, J., Ren, X., … Wei, Q. (2016). A Novel Controlled Release Immunosensor based on Benzimidazole Functionalized SiO 2 and Cyclodextrin Functionalized Gold. Scientific Reports, 6. https://doi.org/10.1038/srep19797

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free